TRIDENT eindsymposium 26 januari 2023
Tijdens het TRIDENT symposium waren in de foyer de volgende (wetenschappelijke) posters van TRIDENT(-gerelateerde) studies te bezichtigen:
Experiences of pregnant women with genome-wide NIPT in a national screening program: a questionnaire study. K.R.M van der Meij , Q.Y.F van de Pol, M.N. Bekker, L. Martin, J. Gitsels van der Wal, E.H. van Vliet-Lachotzki, M.M. Weiss, R.J.H. Galjaard, E.A. Sistermans, M.V.E. Macville, L. Henneman for the Dutch NIPT Consortium
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: follow-up results of the TRIDENT-2 study. L van Prooyen Schuurman, E Sistermans, D Van Opstal, L Henneman, M Bekker, C Bax, M Pieters, K Bouman, S de Munnik, N den Hollander, K Diderich, B Faas, I Feenstra, A Go, M Hoffer , M Joosten, F Komdeur, K Lichtenbelt, M Lombardi, M Polak, F Jehee , H Schuring Blom, S Stevens, M Srebniak, R Suijkerbuijk, G Tan, Sindhunata, K van der Meij, M van Maarle, V Vernimmen, S van Zelderen Bhola, N van Ravesteyn, M Knapen, M Macville, RJ Galjaard, and The Dutch NIPT consortium
Factors involved in the decision to decline prenatal screening with non-invasive prenatal testing (NIPT). L van Prooyen Schuurman, K van der Meij, N van Ravesteyn, N Crombag, J Gitsels van der Wal, C Kooij, L Martin, I Peters, M Polak, E van Vliet Lachotzki , R J Galjaard, L Henneman, the Dutch NIPT Consortium
The psychological impact of receiving findings other than trisomy 21, 18 and 13 with Non-Invasive Prenatal Testing (NIPT). Iris M. Bakkeren, L. Henneman, M.N. Bekker, E.H. van Vliet -Lachotzki, R.J.H. Galjaard and the Dutch NIPT Consortium
Uptake of fetal aneuploidy screening after the introduction of the non‐invasive prenatal test: A national population‐based register study. Karuna van der Meij, M de Groot van Mooren, C Kooij, E Carbo, M Pieters, W Rodenburg, M Bekker, R Galjaard, E Sistermans, M Cornel, L Henneman and the Dutch NIPT Consortium
Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: analysis of subcohort of the TRIDENT-2 study. E.C. Becking, S.A.M. Wirjosoekarto, P.G. Scheffer, J.V.M. Huiskes, M.J. Remmelink, E.A. Sistermans, C.J. Bax, M.M. Weiss, L. Henneman, M.N. Bekker
Early detection of Human CytomegaloVirus (HCMV) infection in pregnant women: large-scale first trimester screening using data generated with whole-genome NIPT. Galuh Astuti, Janette C Rahamat-Langendoen, Annette Reuss, Christian Gilissen, Merryn Macville, Dominique FCM Smeets, Erik A Sistermans, Brigitte HW Faas
MeeroverNIPT.nl; website van het NIPT Consortium in samenwerking met het Erfocentrum. Petra Haak-Bloem, Marloes van Engelen en Jacqueline Pot
Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype. Diane Van Opstal, Stefanie van Veen, Marieke Joosten, Karin E.M. Diderich, Lutgarde C.P. Govaerts, Joke Polak, Nicole van Koetsveld, Marjan Boter, Attie T.J.I. Go, Dimitri N.M. Papatsonis, Krista Prinsen, Lies H. Hoefsloot, Malgorzata I. Srebniak
NIPT is more sensitive for detection of confined placental mosaicism (CPM) than chorionic villus sampling (CVS). Diane Van Opstal, Marieke Joosten, Karin Diderich, Lutgarde Govaerts, Robert-Jan Galjaard, Geerke M. Eggenhuizen, Attie Go, Marjan Boter, Wai Yee Cheung, Nicole van Koetsveld, Fernanda Jehee, Femke de Vries1, Iris Hollink, Lies Hoefsloot, Malgorzata Srebniak
